Ao. Gure et al., SSX - A MULTIGENE FAMILY WITH SEVERAL MEMBERS TRANSCRIBED IN NORMAL TESTIS AND HUMAN CANCER, International journal of cancer, 72(6), 1997, pp. 965-971
Analysis of t(X; 18) translocation in synovial sarcoma had previously
led to the definition of the SSX2 gene, the fusion partner on chromoso
me X. Subsequent screening of testicular cDNA libraries identified 2 h
ighly homologous genes, SSX1 and SSX3. Among these 3 genes, SSX2 has b
een found to be identical to HOM-MEL-40, which codes for an immunogeni
c tumor antigen expressed in various human cancers. SSX2 thus belongs
to the family of cancer/testis (CT) antigens, i.e., immunogenic protei
n antigens with characteristic mRNA expression in normal testis and in
cancer. To define additional CT antigens, we have immune-screened a t
esticular cDNA expression library with an allogeneic serum from a mela
noma patient, and both SSX2 and SSX3 were isolated. Further studies us
ing testicular cDNA and SSX probes defined 2 new members of this gene
family, SSX4 and SSX5, while a shorter cDNA variant of SSX4 was also i
dentified. All 5 members of the SSX family shared strong sequence homo
logy, with nucleotide homology ranging from 88 to 95% and amino acid h
omology ranging from 77 to 91%. Genomic cloning of a prototype SSX gen
e (SSXZ) showed that its coding region is encoded by 6 exons, and the
shortened form of SSX4 cDNA represents an alternatively spliced produc
t lacking the 5th exon. Analysis of SSX mRNA expression by gene-specif
ic RT-PCR confirmed that all 5 SSX genes are expressed in testis. In a
ddition, analysis of a panel of 12 melanoma cell lines showed strong m
RNA expression of either SSX1 (3/12), SSX2 (3/12), SSX4 (1/12), or SSX
5 (1/12), indicating variable activation of the genes in malignant cel
ls. (C) 1997 Wiley-Liss, Inc.